Spectral tussophonobarography as a method for monitoring the effectiveness of cough treatment in patients with COVID-19
https://doi.org/10.18093/0869-0189-2024-4422
Abstract
Dry cough is one of the most common complaints of patients with COVID-19, so it must be treated with antitussives. The effectiveness of prescribed therapy can be controlled by using questionnaires and spectral analysis of cough sounds. The aim was to assess the use of spectral tussophonobarography for monitoring the effectiveness of cough treatment in patients with COVID-19. Methods. The main group consisted of 60 patients with COVID-19 (45% men, 55% women, average age 38.6 (30.1; 49.6) years) with mild or moderate severity and strong complaints of cough. The disease was treated in accordance with clinical recommendations, and antitussives were also used. Cough on the 1st and 8th days of therapy was studied using a visual analogue scale and spectral tussophonobarography, then compared with the induced cough of 30 healthy individuals making up the comparison group (43.3% men and 56.7% women; average age of 36.3 (28.4; 44.8) years). Cough recordings were subjected to a fast Fourier transform algorithm. The following cough characteristics were assessed: duration (ms), ratio of low and medium frequency energy (60 – 600 Hz) to high frequency energy (600 – 6000 Hz), and frequency of maximum sound energy (Hz). Not only of the coughing act as a whole was assessed, but also of each phase separately. Results. On the 8th day of treatment, significant changes in cough characteristics were seen compared to the 1st day, especially in the 2nd phase of the cough act. The duration of cough increased (T = 355.0 (276.0; 407.5) – on the 1st day; T(c) = 432.0 (386.0; 556.0) – on the 8th day; p = 0.0000), lower frequencies began to predominate (Q = 0.281 (0.2245; 0.408) – on the 1st day; Q(c) = 0.4535 (0.3725; 0.619) – on the 8th day; p = 0.0000), the frequency of maximum sound energy decreased (Fmax = 488.5 (282.0; 1220.5) – on the 1st day; Fmax = 347.0 (253.0; 488.0) – on the 8th day; p = 0.0064). No statistically significant differences were found in the studied parameters on the 8th day of treatment as compared with those in healthy individuals. Conclusion. Spectral tussophonobarography revealed that characteristics of cough sounds during treatment of COVID-19 were close to those of healthy individuals.
About the Authors
A. V. BudnevskyRussian Federation
Andrey V. Budnevsky, Doctor of Medicine, Professor, Honored Inventor of the Russian Federation, Head of the Department of Faculty Therapy
ul. Studencheskaya 10, Voronezh, 394622
tel.: (473) 263-81-30
Competing Interests:
The authors report that there is no conflict of interest.
S. N. Avdeev
Russian Federation
Sergey N. Avdeev, Doctor of Medicine, Professor, Academician of Russian Academy of Sciences, Head of the Department of Pulmonology, N.V.Sklifosovsky Institute of Clinical Medicine; Chief Freelance Pulmonologist of the Ministry of Health of the Russian Federation; Director of the National Medical Research Center for Pulmonology
ul. Trubetskaya 8, build. 2, Moscow, 119991
tel.: (495) 708-35-76
Competing Interests:
The authors report that there is no conflict of interest.
E. S. Ovsyannikov
Russian Federation
Evgeniy S. Ovsyannikov, Doctor of Medicine, Professor, Department of Faculty Therapy
ul. Studencheskaya 10, Voronezh, 394622
tel.: (473) 263-81-30
Competing Interests:
The authors report that there is no conflict of interest.
S. N. Feygelman
Russian Federation
Sofia N. Feigelman, Resident, Department of Faculty Therapy
ul. Studencheskaya 10, Voronezh, 394622
tel.: (473) 263-81-30
Competing Interests:
The authors report that there is no conflict of interest.
References
1. Majumder J., Minko T. Recent developments on therapeutic and diagnostic approaches for COVID-19. AAPS J. 2021; 23 (1): 14. DOI: 10.1208/s12248-020-00532-2.
2. Raoult D., Zumla A., Locatelli F. et al. Coronavirus infections: epidemiological, clinical and immunological features and hypotheses. Cell. Stress. 2020; 4 (4): 66–75. DOI: 10.15698/cst2020.04.216.
3. Korpas J., Tomori Z. Cough and other respiratory reflexes. Progress in respiration research. Basel: Karger; 1979. Vol. 12.
4. Piirilä P., Sovijärvi A.R. Objective assessment of cough. Eur. Respir. J. 1995; 8 (11): 1949–1956. DOI: 10.1183/09031936.95.08111949.
5. Ministry of Health of the Russian Federation. [The temporary guidelines: Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)]. Version 18 (October 26, 2023). Available at: https://static-0.minzdrav.gov.ru/system/attachments/attaches/000/064/610/original/%D0%92%D0%9C%D0%A0_COVID-19_V18.pdf [Accessed: December 12, 2023] (in Russian).
6. Budnevsky A.V., Avdeev S.N., Ovsyannikov E.S. et al. [Spectral analysis of cough sounds in patients with COVID-19]. Pul'monologiya. 2022; 32 (6): 834–841. DOI: 10.18093/0869-0189-2022-32-6-834-841 (in Russian).
7. Korpas J., Sadlonova-Korpasova J. Cough sound registration in men. Folia Medica Martiniana. 1984; 10 (1): 167–193.
8. Debrezeni L.A., Korpas J., Salat D. Spectral analysis of cough sounds recorded with and without a noseclip. Bull. Eur. Physiopathol. Respir. 1987; 23 (Suppl. 10): 57–61s.
9. Piirilä P., Sovijärvi A.R.A. Differences in acoustic and dynamic characteristics of spontaneous cough in pulmonary diseases. Chest. 1989; 96 (1): 46–53. DOI: 10.1378/chest.96.1.46.
10. Semenkova G.G., Provotorov V.M., Sychev V.V. et al. [Spectral tussofoiobarography is a method for assessing the reversibility of bronchial obstruction in patients with bronchial asthma]. Pul'monologiya. 2003; (6): 32–36. Available at: https://journal.pulmonology.ru/pulm/article/view/2589 (in Russian).
11. Semenkova G.G., Provotorov V.M., Ovsyannikov E.S. [Study of cough caused by gastroesophageal reflux disease using tousography and spectral toussophonobarography methods]. Pul'monologiya. 2006; (6): 56–61. DOI: 10.18093/0869-0189-2006-6-56-61 (in Russian).
12. Mootassim-Billah S., Van Nuffelen G., Schoentgen J. et al. Assessment of radio (chemo) therapy-related dysphagia in head and neck cancer patients based on cough-related acoustic features: a prospective phase II national clinical trial (ACCOUGH-P/A trial). Trials. 2023; 24 (1): 619. DOI: 10.1186/s13063-023-07660-y.
13. Abeyratne U.R., Swarnkar V., Triasih R., Setyati A. Cough sound analysis – a new tool for diagnosing pneumonia. Annu. Int. Conf. IEEE Eng. Med. Biol Soc. 2013; 2013: 5216–5219. DOI: 10.1109/EMBC.2013.6610724.
Supplementary files
Review
For citations:
Budnevsky A.V., Avdeev S.N., Ovsyannikov E.S., Feygelman S.N. Spectral tussophonobarography as a method for monitoring the effectiveness of cough treatment in patients with COVID-19. PULMONOLOGIYA. 2025;35(1):42-48. (In Russ.) https://doi.org/10.18093/0869-0189-2024-4422